Pharma more optimistic about future despite upcoming industry consolidation

More than 69% of senior players within the pan-world pharma industry expect to see a year-on-year increase in profits in 2014 while, longer term, 89% expect to see further shrinkage in the sector due to consolidation.

Over 42% expect investment in R&D to also reduce, according to the new Industry Healthcheck, an extensive global survey undertaken by eyeforpharma. Representing the views of 1,600 global participants from all sectors of pharma, The Industry Healthcheck provides a unique insight into the sector, highlighting both key concerns and hopes for the future.

Pharma reputation remains key concern

Pharma’s reputation is still a key concern. Less than 22% thought it was improving amongst the general public. This increased to over 35% amongst health care professionals, but still a low figure. Yet pharma didn’t consider itself entirely at fault: nearly 34% claimed that the industry was being hamstrung by the tight regulatory structure that prevents it from defending its own corner.